Phase II study of thalidomide, Interleukin-2 (IL-2), and granulocyte macrophage-colony stimulating factor (GM-CSF) in patients (pts) with metastatic renal cell carcinoma (MRCC) No significant ...
SAN ANTONIO -- Men with intermediate- and high-risk prostate cancer treated with external-beam pelvic radiotherapy (EBRT) had better quality of life (QOL) outcomes when the combined prostate ...
Originally described in 1917, low dose-rate (LDR) prostate brachytherapy represents the earliest form of radiotherapy for prostate cancer. 1 During the early years, seed placement through an open ...
Brachytherapy is a form of radiation therapy, by which a radioactive source is placed close to the tumor, either directly adjacent to it or inside the tumor itself. This procedure delivers a high dose ...
ARLINGTON, Va., March 1, 2017 - Results from a new prospective clinical trial indicate that high-dose-rate (HDR) brachytherapy administered in a single, 19 Gray (Gy) treatment may be a safe and ...
(HealthDay News) — Iodine-125 permanent interstitial implantation is associated with long-term, biochemical control of localized prostate cancer, according to a study published online in the Journal ...
Prostate brachytherapy (BT) is a form of radiation therapy used to treat prostate cancer. The technique involves placing encapsulated radioisotopes inside or nearby the tumor. The radioactive ...
This Review highlights current areas of controversy and development in the field of transperineal permanent prostate seed implantation brachytherapy (PPI), in particular the technological evolution of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback